Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

TB-500 / BPC-157 / KPV Blend Dosage & Reconstitution

TB-500 10 mg + BPC-157 10 mg + KPV 10 mg. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

10 mg/mL · 10000 mcg/mL

Your Answer — TB-500 / BPC-157 / KPV Blend

30 mg in 3 mL
6Draw To This Line
0.06That's This Many mL
50Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 6
30 mg ÷ 3 mL = 10 mg/mL  →  600 mcg ÷ 10 mg/mL = 0.06 mL  →  × 100 = 6 units
Looks good. Draw to 6 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 50 doses.
When to dose
Time of dayNo particular time of day has been established.
FoodNo fasting requirement has been established.

The studies behind this compound did not test timing or food state as variables, so we are not going to invent a rule. Pick a time you can keep to consistently.

2Week-By-Week Plan — TB-500 / BPC-157 / KPV Blend

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Weeks 1–2 600 mcg daily 0.06 mL 6 u 14 8.4 mg
Weeks 3–4 900 mcg daily 0.09 mL 9 u 14 12.6 mg
Week 5 onward
per 4 weeks from here on
1500 mcg daily 0.15 mL 15 u 28 42 mg
Time until the top dose
4 weeks
Peptide used getting there
21 mg
Vials you'll need
1 × 30 mg
Once you're at the top dose
42 mg / 4 wk · 1.4 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — TB-500 / BPC-157 / KPV Blend

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Low reported 600 mcg 1× daily · 200 mcg of each compound 0.06 mL 6 u 50 doses
Standard 900 mcg 1× daily · 300 mcg of each compound 0.09 mL 9 u 33 doses
Upper reported 1500 mcg 1× daily · 500 mcg of each compound 0.15 mL 15 u 20 doses
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About TB-500 / BPC-157 / KPV Blend

Multi-Compound Blends
Also known as
TB-500 10 mg + BPC-157 10 mg + KPV 10 mg
Class
Multi-Compound Blends
Route
Subcutaneous
Half-life
Mixed
Evidence tier
Preclinical

An equal-thirds repair and anti-inflammatory combination — 10 mg of each component in a 30 mg vial. Because the three are pooled at a fixed 1:1:1 ratio you cannot move one without moving the others, so every dose delivers exactly one third of the total to each. A 900 mcg dose is 300 mcg apiece.

Buy TB-500 / BPC-157 / KPV Blend

Common Questions — TB-500 / BPC-157 / KPV Blend

How much bacteriostatic water do I add to a 30 mg vial of TB-500 / BPC-157 / KPV Blend?

Adding 3 mL of bacteriostatic water to a 30 mg vial gives 10 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.

What dose of TB-500 / BPC-157 / KPV Blend is used in research?

Published and reported figures for TB-500 / BPC-157 / KPV Blend run from 600 mcg to 1500 mcg, typically 1× daily (200 mcg each). This site lists each figure with the source it came from rather than giving a single recommended number.

How many units on the syringe is a 600 mcg dose of TB-500 / BPC-157 / KPV Blend?

At 10 mg/mL, a 600 mcg dose is 6 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 50 doses.

How strong is the evidence behind these TB-500 / BPC-157 / KPV Blend doses?

TB-500 / BPC-157 / KPV Blend is graded preclinical. Laboratory and animal data only. No human dosing trials have been published. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.

Why these three are combined

30 mg vial
What is in the vial
  • TB-500 10 mg
  • BPC-157 10 mg
  • KPV 10 mg

This is the BPC-157 / KPV pairing with TB-500 added. Repair, anti-inflammatory activity and remodelling in one vial, at an even 10 mg of each.

It sits between the two-compound repair blends and the GHK-Cu-heavy GLOW family: no cosmetic component, but broader repair coverage than either two-compound blend on its own.

The ratio matters. An even three-way split, so a 600 mcg dose is 200 mcg of each.

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
See component entries: TB-500, BPC-157, KPV No blend-specific literature exists
No study has tested this combination as such. The ranges above are the ones where all three components sit inside their own reported figures at the same time.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

Other multi-compound blends peptides

Compounds in the same class, or browse the full catalogue.

BPC-157 / KPV Blend

An equal-parts repair and anti-inflammatory pairing — 10 mg of each in a 20 mg vial, so every dose splits evenly down the middle a…

CJC-1295 / Ipamorelin Blend

A GHRH analogue paired with a selective ghrelin receptor agonist — the pairing rationale is that the two receptors act synergistic…

All 72 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.

Need this on one page to print, screenshot or send?

Make a dose card →